Evidence map›Paper›PMID 27493992›Full record

ArticleScience advances2016

Analysis of neural crest-derived clones reveals novel aspects of facial development.

Marketa Kaucka, Evgeny Ivashkin, Daniel Gyllborg, Tomas Zikmund, Marketa Tesarova, Jozef Kaiser, Meng Xie, Julian Petersen, Vassilis Pachnis, Silvia K Nicolis and 11 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The subfunctionalization ofFrontiers in cell and developmental biology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Evolutionary mechanisms modulating the mammalian skull development.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 8 countries.

Marketa KauckaDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm SE-171 77, Sweden.
Evgeny IvashkinDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm SE-171 77, Sweden.; Research Center of Neurology, 125367 Moscow, Russia.
Daniel GyllborgUnit of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm SE-171 77, Sweden.
Tomas ZikmundCentral European Institute of Technology, Brno University of Technology, 616 00 Brno, Czech Republic.
Marketa TesarovaCentral European Institute of Technology, Brno University of Technology, 616 00 Brno, Czech Republic.ORCID 0000-0002-5200-7365
Jozef KaiserCentral European Institute of Technology, Brno University of Technology, 616 00 Brno, Czech Republic.ORCID 0000-0002-7397-125X
Meng XieDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm SE-171 77, Sweden.
Julian PetersenDepartment of Molecular Neurosciences, Medical University of Vienna, Vienna 1190, Austria.
Vassilis PachnisDivision of Molecular Neurobiology, Medical Research Council National Institute for Medical Research, London NW7 1AA, UK.
Silvia K NicolisDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.ORCID 0000-0003-0378-3808
Tian YuDepartment of Craniofacial Development and Stem Cell Biology, King's College London Dental Institute, Guy's Hospital, London SE1 9RT, UK.
Paul SharpeDepartment of Craniofacial Development and Stem Cell Biology, King's College London Dental Institute, Guy's Hospital, London SE1 9RT, UK.
Ernest ArenasUnit of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm SE-171 77, Sweden.ORCID 0000-0003-0197-6577
Hjalmar BrismarScience for Life Laboratory, Royal Institute of Technology, Solna 17121, Sweden.ORCID 0000-0003-0578-4003
Hans BlomScience for Life Laboratory, Royal Institute of Technology, Solna 17121, Sweden.ORCID 0000-0002-5584-9170
Hans CleversHubrecht Institute of the Royal Netherlands Academy of Arts and Sciences, Princess Maxima Centre and University Medical Centre Utrecht, 3584 Utrecht, Netherlands.
Ueli SuterDepartment of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich CH-8093, Switzerland.
Andrei S ChaginDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm SE-171 77, Sweden.
Kaj FriedDepartment of Neuroscience, Karolinska Institutet, Stockholm SE-171 77, Sweden.ORCID 0000-0002-9997-7078
Andreas HellanderDepartment of Information Technology, Uppsala University, Uppsala SE-751 05, Sweden.
Igor AdameykoDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm SE-171 77, Sweden.; Department of Molecular Neurosciences, Medical University of Vienna, Vienna 1190, Austria.
Karolinska Institutet · SECentral European Institute of Technology · CZGuy's Hospital · GBKTH Royal Institute of Technology · SEETH Zurich · CHMedical Research Council · GBMedical University of Vienna · ATRoyal Netherlands Academy of Arts and Sciences · NLUniversity of Milano-Bicocca · ITUppsala University · SE

Funding

StochSS: A Next-Generation Toolkit for Simulation-Driven Biological DiscoveryR01EB014877 · NIBIB · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI PETZOLD, LINDA R. · 2012 to 2022
$3.9M
NIBIB NIH HHS R01 EB014877
6 · The paper itself

Abstract

Cranial neural crest cells populate the future facial region and produce ectomesenchyme-derived tissues, such as cartilage, bone, dermis, smooth muscle, adipocytes, and many others. However, the contribution of individual neural crest cells to certain facial locations and the general spatial clonal organization of the ectomesenchyme have not been determined. We investigated how neural crest cells give rise to clonally organized ectomesenchyme and how this early ectomesenchyme behaves during the developmental processes that shape the face. Using a combination of mouse and zebrafish models, we analyzed individual migration, cell crowd movement, oriented cell division, clonal spatial overlapping, and multilineage differentiation. The early face appears to be built from multiple spatially defined overlapping ectomesenchymal clones. During early face development, these clones remain oligopotent and generate various tissues in a given location. By combining clonal analysis, computer simulations, mouse mutants, and live imaging, we show that facial shaping results from an array of local cellular activities in the ectomesenchyme. These activities mostly involve oriented divisions and crowd movements of cells during morphogenetic events. Cellular behavior that can be recognized as individual cell migration is very limited and short-ranged and likely results from cellular mixing due to the proliferation activity of the tissue. These cellular mechanisms resemble the strategy behind limb bud morphogenesis, suggesting the possibility of common principles and deep homology between facial and limb outgrowth.

Indexed as

Cell DifferentiationMorphogenesisOrganogenesisAnimalsCell MovementClone CellsEctodermFaceGene ExpressionGenes, ReporterImaging, Three-DimensionalMesodermMiceModels, AnatomicNeural CrestPhenotypeclonal envelopesEarly face developmentembryonic developmentmigrationmorphogenesisneural crest cells

Identifiers

PMID27493992
PMCPMC4972470
OpenAlexW2482194704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.